Si Bone Financials
SIBN Stock | USD 18.44 0.97 5.55% |
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Current Ratio | 5.82 | 8.11 |
|
|
The essential information of the day-to-day investment outlook for Si Bone includes many different criteria found on its balance sheet. An individual investor should monitor Si Bone's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Si Bone.
Net Income |
|
SIBN | Select Account or Indicator |
Si Bone Earnings Geography
Si Bone Stock Summary
Si Bone competes with CONMED, Orthopediatrics Corp, Pulmonx Corp, Iradimed, and Orthofix Medical. SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. The company was incorporated in 2008 and is headquartered in Santa Clara, California. Si Bone operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 352 people.Specialization | Health Care, Health Care Equipment & Services |
Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
ISIN | US8257041090 |
CUSIP | 825704109 |
Location | California; U.S.A |
Business Address | 471 El Camino |
Sector | Health Care Equipment & Supplies |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | si-bone.com |
Phone | 408 207 0700 |
Currency | USD - US Dollar |
Si Bone Key Financial Ratios
Return On Equity | -0.22 | ||||
Profit Margin | (0.24) % | ||||
Operating Margin | (0.19) % | ||||
Price To Sales | 4.67 X | ||||
Revenue | 138.89 M |
Si Bone Key Balance Sheet Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Total Assets | 223.1M | 190.5M | 157.6M | 230.4M | 265.0M | 278.2M | |
Other Current Liab | 10.2M | 11.0M | 12.1M | 17.5M | 20.1M | 21.1M | |
Net Debt | (14.1M) | (22.9M) | 18.7M | 5.7M | 6.6M | 6.9M | |
Retained Earnings | (239.3M) | (295.8M) | (357.1M) | (400.4M) | (360.4M) | (342.4M) | |
Accounts Payable | 3.3M | 3.2M | 6.3M | 4.6M | 5.3M | 3.4M | |
Cash | 53.6M | 63.4M | 20.7M | 33.3M | 38.3M | 30.3M | |
Other Assets | 315K | 374K | 400K | 375K | 337.5K | 406.6K | |
Net Receivables | 13.6M | 14.2M | 20.7M | 22.0M | 25.2M | 26.5M | |
Inventory | 5.6M | 11.5M | 17.3M | 20.2M | 23.3M | 24.5M | |
Other Current Assets | 5.1M | 6.3M | 2.4M | 3.2M | 3.6M | 2.6M | |
Total Liab | 53.8M | 56.1M | 59.3M | 61.1M | 70.2M | 72.0M | |
Total Current Assets | 218.2M | 175.9M | 137.6M | 211.4M | 243.1M | 255.3M | |
Common Stock | 258.1M | 408.1M | 429.9M | 455.2M | 4.6K | 4.4K | |
Net Tangible Assets | 63.0M | 169.4M | 134.4M | 98.3M | 113.0M | 118.7M | |
Long Term Debt | 39.5M | 35.0M | 35.2M | 36.1M | 41.5M | 35.2M | |
Long Term Debt Total | 39.0M | 34.9M | 39.5M | 35.2M | 40.4M | 37.0M | |
Capital Surpluse | 246.9M | 258.1M | 408.1M | 455.2M | 523.4M | 549.6M | |
Other Liab | 362K | 854K | 57K | 30K | 27K | 25.7K | |
Net Invested Capital | 208.8M | 169.4M | 133.5M | 205.4M | 236.3M | 134.8M | |
Net Working Capital | 204.8M | 159.0M | 116.4M | 187.9M | 216.1M | 143.6M |
Si Bone Key Income Statement Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Total Revenue | 73.4M | 90.2M | 106.4M | 138.9M | 159.7M | 167.7M | |
Gross Profit | 64.5M | 79.7M | 90.7M | 109.4M | 125.8M | 132.1M | |
Operating Income | (38.6M) | (51.7M) | (59.6M) | (46.9M) | (42.2M) | (44.3M) | |
Ebit | (37.6M) | (51.7M) | (58.4M) | (39.9M) | (35.9M) | (37.7M) | |
Research Development | 9.5M | 12.4M | 13.6M | 15.0M | 17.3M | 9.6M | |
Ebitda | (36.5M) | (49.6M) | (55.0M) | (34.4M) | (31.0M) | (32.6M) | |
Cost Of Revenue | 8.9M | 10.4M | 15.7M | 29.5M | 33.9M | 35.6M | |
Income Before Tax | (43.7M) | (56.6M) | (61.3M) | (43.3M) | (39.0M) | (41.0M) | |
Net Income | (48.5M) | (60.1M) | (62.9M) | (43.3M) | (39.0M) | (41.0M) | |
Income Tax Expense | 4.8M | 3.6M | 1.6M | 5.3M | 6.0M | 3.4M | |
Interest Expense | 6.1M | 5.4M | 2.8M | 3.5M | 4.0M | 4.1M | |
Interest Income | 1.1M | 186K | 1.3M | 5.4M | 6.3M | 6.6M | |
Net Interest Income | (5.0M) | (5.2M) | (1.5M) | 2.0M | 2.3M | 2.4M |
Si Bone Key Cash Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Change To Inventory | (274K) | (5.8M) | (5.7M) | (4.7M) | (4.2M) | (4.0M) | |
Change In Cash | 43.1M | 9.8M | (42.7M) | 12.6M | 11.3M | 11.9M | |
Free Cash Flow | (33.2M) | (45.9M) | (51.2M) | (26.5M) | (23.9M) | (25.1M) | |
Depreciation | 1.1M | 2.1M | 3.5M | 5.4M | 6.2M | 6.6M | |
Other Non Cash Items | 292K | 288K | 730K | (29K) | (33.4K) | (31.7K) | |
Capital Expenditures | 2.6M | 6.4M | 9.5M | 7.8M | 9.0M | 9.4M | |
Net Income | (43.7M) | (56.6M) | (61.3M) | (43.3M) | (39.0M) | (41.0M) | |
End Period Cash Flow | 53.6M | 63.4M | 20.7M | 33.3M | 38.3M | 28.0M | |
Change To Netincome | 7.6M | 14.0M | 20.4M | 23.4M | 26.9M | 28.2M | |
Investments | (60.4M) | 58.0M | 6.7M | (40.8M) | (46.9M) | (49.3M) |
SIBN Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Si Bone's current stock value. Our valuation model uses many indicators to compare Si Bone value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Si Bone competition to find correlations between indicators driving Si Bone's intrinsic value. More Info.Si Bone is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . At this time, Si Bone's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Si Bone's earnings, one of the primary drivers of an investment's value.Si Bone's Earnings Breakdown by Geography
Si Bone Systematic Risk
Si Bone's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Si Bone volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Si Bone correlated with the market. If Beta is less than 0 Si Bone generally moves in the opposite direction as compared to the market. If Si Bone Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Si Bone is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Si Bone is generally in the same direction as the market. If Beta > 1 Si Bone moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Si Bone Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Si Bone's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Si Bone growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Si Bone February 25, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Si Bone help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Si Bone. We use our internally-developed statistical techniques to arrive at the intrinsic value of Si Bone based on widely used predictive technical indicators. In general, we focus on analyzing SIBN Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Si Bone's daily price indicators and compare them against related drivers.
Downside Deviation | 2.26 | |||
Information Ratio | 0.1454 | |||
Maximum Drawdown | 22.82 | |||
Value At Risk | (3.76) | |||
Potential Upside | 5.29 |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Si Bone. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. To learn how to invest in SIBN Stock, please use our How to Invest in Si Bone guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Si Bone. If investors know SIBN will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Si Bone listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.91) | Revenue Per Share | Quarterly Revenue Growth 0.186 | Return On Assets | Return On Equity |
The market value of Si Bone is measured differently than its book value, which is the value of SIBN that is recorded on the company's balance sheet. Investors also form their own opinion of Si Bone's value that differs from its market value or its book value, called intrinsic value, which is Si Bone's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Si Bone's market value can be influenced by many factors that don't directly affect Si Bone's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Si Bone's value and its price as these two are different measures arrived at by different means. Investors typically determine if Si Bone is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Si Bone's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.